1. Home
  2. RDHL vs MLEC Comparison

RDHL vs MLEC Comparison

Compare RDHL & MLEC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Redhill Biopharma Ltd.

RDHL

Redhill Biopharma Ltd.

N/A

Current Price

$0.81

Market Cap

4.6M

Sector

Health Care

ML Signal

N/A

Logo Moolec Science SA

MLEC

Moolec Science SA

HOLD

Current Price

$7.50

Market Cap

4.7M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
RDHL
MLEC
Founded
2009
2008
Country
Israel
Cayman Islands
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Blank Checks
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
4.6M
4.7M
IPO Year
2012
N/A

Fundamental Metrics

Financial Performance
Metric
RDHL
MLEC
Price
$0.81
$7.50
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
21.5K
29.2K
Earning Date
11-28-2025
04-15-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$381.91
$20.42
Revenue Next Year
N/A
$30.00
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.78
$0.21
52 Week High
$3.31
$23.22

Technical Indicators

Market Signals
Indicator
RDHL
MLEC
Relative Strength Index (RSI) 35.82 38.94
Support Level $0.80 $5.13
Resistance Level $1.07 $7.95
Average True Range (ATR) 0.05 1.04
MACD 0.00 -0.51
Stochastic Oscillator 19.01 9.50

Price Performance

Historical Comparison
RDHL
MLEC

About RDHL Redhill Biopharma Ltd.

Redhill Biopharma Ltd is a specialty biopharmaceutical company focused on gastrointestinal diseases. The company is dedicated to advancing its development pipeline of clinical-stage therapeutic candidates. It also commercializes GI-related products in the U.S., including Talicia (omeprazole, amoxicillin, and rifabutin) and Aemcolo (rifamycin). Currently, the company's pipeline consists of five therapeutic candidates: Opaganib, RHB-107, RHB-102, RHB-204, and RHB-104, the majority of which are in clinical development.

About MLEC Moolec Science SA

Moolec Science SA is a science-based ingredient company focused on producing real animal proteins in plants through Molecular Farming, a technology in the alternative protein landscape. Its purpose is to upgrade the taste, nutrition, and affordability of alternative protein products while building a more sustainable and equitable food system. The company has various products in its pipeline, such as; TSP Valorasoy which is a soy protein product to produce vegetable proteins with texture and fibrousness similar to those of meat, Glaso, a safflower oil with high levels of gamma-linolenic acid, SPC2 which is a plant-based chymosin, YEEA1, an extract derived from a novel yeast biomass with specific properties, and others. The company's maximum revenues from operations in Argentina.

Share on Social Networks: